HMGB1–Carbenoxolone Interactions: Dynamics Insights from Combined Nuclear Magnetic Resonance and Molecular Dynamics-Reference-Cited by-同舟云学术

HMGB1–Carbenoxolone Interactions: Dynamics Insights from Combined Nuclear Magnetic Resonance and Molecular Dynamics

Published:2011-02-03 Issue:5 Volume:6 Page:1171-1180
ISSN:1861-4728
Container-title:Chemistry – An Asian Journal
language:en
Short-container-title:Chem. Asian J.

Author:

Mollica Luca¹²,Morra Giulia³,Colombo Giorgio³,Musco Giovanna¹

Affiliation:

1. Dulbecco Telethon Institute, Biomolecular NMR Laboratory c/o Center of Genomics, Bioinformatics and Biostatistics, S. Raffaele Scientific Institute, Via Olgettina 58, 20132, Milano (Italy), Fax: (+39) 0226434153

2. Present address: Protein Dynamics and Flexibility by NMR, Institut de Biologie Structurale, 41 Rue Jules Horowitz, Grenoble 38027 (France)

3. Istituto di Chimica del Riconoscimento Molecolare, Consiglio nazionale delle Ricerche, Via Mario Bianco 9, 20131, Milano (Italy)

Publisher

Wiley

Subject

General Chemistry,Biochemistry,Organic Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/asia.201000726

Reference41 articles.

1. Tail-Mediated Collapse of HMGB1 Is Dynamic and Occurs via Differential Binding of the Acidic Tail to the A and B Domains

2. Structure of the A-Domain of HMG1 and Its Interaction with DNA as Studied by Heteronuclear Three- and Four-Dimensional NMR Spectroscopy

3. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity

4. Glycyrrhizin Binds to High-Mobility Group Box 1 Protein and Inhibits Its Cytokine Activities

5. The binding domain of the HMGB1 inhibitor carbenoxolone: Theory and experiment

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A patent review on HMGB1 inhibitors for the treatment of liver diseases;Expert Opinion on Therapeutic Patents;2024-03-03

2. Inhibition of DAMP actions in the tumoral microenvironment using lactoferrin-glycyrrhizin conjugate for glioblastoma therapy;Biomaterials Research;2023-05-20

3. Inhibition of DAMP Actions in the Tumoral Microenvironment Using Lactoferrin-Glycyrrhizin Nanoconjugate for Glioblastoma Therapy;2023-02-10

4. Discovery of 5,5′-Methylenedi-2,3-Cresotic Acid as a Potent Inhibitor of the Chemotactic Activity of the HMGB1·CXCL12 Heterocomplex Using Virtual Screening and NMR Validation;Frontiers in Chemistry;2020-11-26

5. N-glycosylation of High Mobility Group Box 1 protein (HMGB1) modulates the interaction with glycyrrhizin: A molecular modeling study;Computational Biology and Chemistry;2020-10